LSD1 inhibitors provide a promising therapeutic strategy of pancreatic cancers through LSD1-independent manner

被引：0
|
作者：
Zhang, Zhiheng [1 ]
Aoki, Haruna [1 ]
Hirao, Takuya [2 ]
Aoki, Shigeki [3 ]
机构：
[1] Chiba Univ, Grad Sch Pham Sci, Lab Biopharm, Chiba, Japan
[2] Inter Univ Hlth & Welf, Sch Pham Sci, Otawara, Japan
[3] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chiba, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3207
引用
收藏
页码：2139 / 2139
页数：1
相关论文
共 50 条
  • [41] ETV1 PROMOTES HCC METASTASIS THROUGH BOTH INCREASING LSD1 ACTIVITY BY FACILITATING FAD SYNTHESIS AND UPREGULATING LSD1 EXPRESSION
    Xia, Limin
    GASTROENTEROLOGY, 2020, 158 (06) : S1275 - S1276
  • [42] An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors
    Zheng, Yi-Chao
    Chang, Jiao
    Zhang, Ting
    Suo, Feng-Zhi
    Chen, Xiao-Bing
    Liu, Ying
    Zhao, Bing
    Yu, Bin
    Liu, Hong-Min
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (23) : 2496 - 2504
  • [43] Recent advances of LSD1/KDM1A inhibitors for disease therapy
    Zhang, Chaofeng
    Wang, Zhiyuan
    Shi, Yuting
    Yu, Bin
    Song, Yihui
    BIOORGANIC CHEMISTRY, 2023, 134
  • [44] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Yuan Fang
    Guochao Liao
    Bin Yu
    Journal of Hematology & Oncology, 12
  • [45] LSD1 inhibitors disrupt the GFI1 transcription repressor complex
    Maiques-Diaz, Alba
    Lynch, James T.
    Spencer, Gary J.
    Somervaille, Tim C. P.
    MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (04):
  • [46] A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1
    Izumi, Kenta
    Tajima, Ken
    Aditya, Wirawan
    Wira, Winardi
    Matsumoto, Naohisa
    Miyashita, Yosuke
    Hayakawa, Daisuke
    Mitsuishi, Yoichiro
    Shimada, Naoko
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    CANCER SCIENCE, 2022, 113 : 581 - 581
  • [47] A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
    Wirawan, Aditya
    Tajima, Ken
    Takahashi, Fumiyuki
    Mitsuishi, Yoichiro
    Winardi, Wira
    Hidayat, Moulid
    Hayakawa, Daisuke
    Matsumoto, Naohisa
    Izumi, Kenta
    Asao, Tetsuhiko
    Ko, Ryo
    Shimada, Naoko
    Takamochi, Kazuya
    Suzuki, Kenji
    Abe, Masaaki
    Hino, Okio
    Sekido, Yoshitaka
    Takahashi, Kazuhisa
    MOLECULAR CANCER RESEARCH, 2022, 20 (01) : 127 - 138
  • [48] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Fang, Yuan
    Liao, Guochao
    Yu, Bin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [49] The histone demethylase LSD1/KDM1A as therapeutic target in AML
    Berg, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 272 - +
  • [50] Simultaneous targeting of LSD1 and PRMT5 through chimeric inhibitors as a novel therapeutic approach against leukemia
    Fiorentino, F.
    Pignata, L.
    Arceci, E.
    Di Bello, E.
    Bonaldi, T.
    Barone, M.
    Madl, T.
    Jeyasekharan, A.
    Mattevi, A.
    Valente, S.
    Guccione, E.
    Mai, A.
    FEBS OPEN BIO, 2024, 14 : 18 - 19
12345